<DOC>
	<DOCNO>NCT02053168</DOCNO>
	<brief_summary>Collect data safety , performance , effectiveness Phasix Mesh subject require primary ventral incisional hernia .</brief_summary>
	<brief_title>A Prospective , Multicenter All Comers Study Phasix Mesh Ventral Incisional Hernia Repair</brief_title>
	<detailed_description>Pilot Study patient across wound class recurrence</detailed_description>
	<mesh_term>Hernia</mesh_term>
	<mesh_term>Hernia , Ventral</mesh_term>
	<mesh_term>Incisional Hernia</mesh_term>
	<criteria>Subject subject 's legally authorize representative must willing give write informed consent Subject must diagnose ventral incisional hernia Subject must willing undergo open ventral hernia repair able undergo study procedure outline protocol . Subject active smoker ( attempts quit smoke within two week surgery fail patient still active smoker time surgery ) . Subject 's hernia recur four time . Subject 's body mass index ( BMI ) &gt; 40 kg/m2 . Subject peritonitis . Subject suspect placed chemotherapy medication part study . Chronic steroid use immunosuppression drug ( &gt; 6 month ) . Subject cirrhosis , and/or ascites . Subject American Society Anesthesiology Class 4 5 . Subject pregnant planning become pregnant course study . Subject know infected human immunodeficiency virus ( HIV ) . Subject life expectancy le 2 year time enrollment . Subject treated investigational product past 30 day . Subject part site personnel directly involve study Subject known allergy tetracycline hydrochloride kanamycin sulfate , test device component material . Subject condition opinion Investigator would preclude use study device , preclude subject complete followup requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>